Skip to Main Content

Paper Details

Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension.
Nat Commun
19
2022
human, hyperlipidemia, hypertension
Author NameAffiliation
QiPing FengVanderbilt University Medical Center
Vern Eric KerchbergerVanderbilt University Medical Center
Vern Eric KerchbergerVanderbilt University Medical Center
Scott D NelsonVanderbilt University Medical Center
Qingxia ChenVanderbilt University Medical Center
Qingxia ChenVanderbilt University School of Medicine
Bingshan LiVanderbilt University School of Medicine
Bingshan LiVanderbilt Genetics Institute, Vanderbilt University Medical Center
Todd L EdwardsVanderbilt Genetics Institute, Vanderbilt University Medical Center
Todd L EdwardsTennessee Valley Healthcare System ()/Vanderbilt University
Todd L EdwardsVanderbilt University Medical Center
Todd L EdwardsInstitute for Medicine and Public Health, Vanderbilt University Medical Center
Nancy J CoxVanderbilt Genetics Institute, Vanderbilt University Medical Center
Nancy J CoxVanderbilt University Medical Center
Nancy J CoxVanderbilt Genetics Institute, Vanderbilt University Medical Center
Nancy J CoxVanderbilt University Medical Center
Elizabeth J PhillipsVanderbilt University Medical Center
Elizabeth J PhillipsVanderbilt University School of Medicine
Elizabeth J PhillipsVanderbilt University Medical Center
Elizabeth J PhillipsInstitute for Infectious Diseases and Immunology, Murdoch University
Dan M RodenVanderbilt University Medical Center
Dan M RodenVanderbilt University Medical Center
Dan M RodenVanderbilt University School of Medicine
Joshua C DennyNational Institutes of Health
Joshua C DennyNational Human Genome Research Institute, National Institutes of Health
Wei-Qi WeiVanderbilt University Medical Center
  • 1 - 26

Datasets

Release 1.2